Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence.
JAMA neurology · 2023 · 163 citations · William Gallentine
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.
The Lancet. Neurology · 2021 · 399 citations · Edward Smith
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.
Neurology · 2024 · 70 citations · Edward Smith
International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis.
Neurology(R) neuroimmunology & neuroinflammation · 2021 · 156 citations · William Gallentine
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
JAMA neurology · 2021 · 183 citations · William Gallentine
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial.
The Lancet. Neurology · 2023 · 106 citations · Sarah Neuhaus
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.
Annals of neurology · 2023 · 72 citations · Klaus-Georg Werner
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
JAMA neurology · 2022 · 114 citations · Edward Smith